Prevention of mpox by JYNNEOS vaccination: a case-control study comparing test-negative and alternative-disease control populations

Clicks: 2
ID: 338241
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #373 of 378 articles by views in american journal of epidemiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 378 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Risk-based vaccine recommendations complicate observational studies of vaccine effectiveness (VE), since recipients and non-recipients may differ in infection risk and likelihood of testing. For JYNNEOS—recommended for men who have sex with men at high mpox risk—prior studies have used differing control populations to estimate VE, with uncertain comparability. We conducted a multi-armed case-control study enrolling mpox cases (N=198), monkeypox virus (MPXV)-negative controls (N=208), and gonorrhea controls (N=155) reported to the California Department of Public Health between November 2022 and October 2024, conducting telephone interviews to capture behavioral risk data typically absent from surveillance and administrative records. Among recipients of 2 pre-exposure JYNNEOS doses, adjusted VE was 89.9% (95% CI, 69.6–96.7%) versus test-negative controls and 92.0% (70.6–97.8%) versus gonorrhea controls. Without behavioral adjustment, however, VE estimates using MPXV-negative controls were lower (50.4–65.4%) than those using gonorrhea controls (61.3–71.3%). Controls diagnosed with an alternative sexually transmitted infection may offer a better comparison group than test-negative controls for JYNNEOS VE studies based on disease surveillance or administrative records, although collection of risk factor data may be necessary to mitigate bias under either design.
Reference Key
openalex_W7225096141 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kayla Saadeh, Eric Tang, Kelly D. Johnson, Samuel Holland, Nicole Burghardt, Roshani Fernando, Kimberly Gonzalez Barrera, Cindy Hernandez, Lauren Granskog, Kieran Lorenz, Jarett Maycott, John McGinley, Marissa Ramos, Timothy Lo, Edwin Chojolan, Awa Keinde, Kathleen R. Jacobson, Robert E. Snyder, Joseph A. Lewnard
Are you one of these authors? Claim your profile
Journal american journal of epidemiology
Year 2026
DOI
10.1093/aje/kwag257
URL
https://doi.org/10.1093/aje/kwag257
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.